F-A-S-T: A refocused, intensified, administrative tuberculosis transmission control strategy

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 4, 2015, Pages 381-384

  Barrera, E ^a   Livchits, V ^a   Nardell, E ^b  

^a PARTNERS IN HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; COUGHING; DISEASE SURVEILLANCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPUTUM SMEAR; TUBERCULOSIS CONTROL; TUBERCULOSIS RAPID TEST; COMMUNICABLE DISEASE CONTROL; PROCEDURES; TRANSMISSION; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

COMMUNICABLE DISEASE CONTROL; HUMANS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84925622084     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0680     Document Type: Review

References (13)

1. Bacaer N, Ouifki R, Pretorius C, Wood R, Williams B. Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol 2008; 57: 557-593.
2. Bekker L G, Wood R. The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis 2010; 50 (Suppl 3): S208-S214.
3. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
4. Gandhi N R, Moll A, Sturm A W, et al. Extensively drugresistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580.
5. Gelmanova I Y, Keshavjee S, Golubchikova V T, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007; 85: 703-711.
6. Farley J E, Tudor C, Mphahlele M, et al. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. Int J Tuberc Lung Dis 2012; 16: 82-89.
7. World Health Organization. WHO policy on TB infection control in health-care facilities, congregate settings and households. WHO/HTM/TB/2009.419. Geneva, Switzerland: WHO, 2009.
8. Willingham F F, Schmitz T L, Contreras M, et al. Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerg Infect Dis 2001; 7: 123-127.
9. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLOS ONE 2012; 7: e40774.
10. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976; 57: 275-299.
11. Dharmadhikari A S, Mphahlele M, Venter K, et al. Rapid impact of effective treatment on transmission of multidrugresistant tuberculosis. Int J Tuberc Lung Dis 2014; 18: 1019-1025.
12. van't Hoog A H, Cobelens F, Vassall A, et al. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert® MTB/RIF assay for TB diagnosis: a decision analysis. PLOS ONE 2013; 8: e82786.
13. Menzies N A, et al. Population health impact and costeffectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLOS MED 2012; 9: e1001347.